Literature DB >> 26604570

Role of oxidative stress in the pathogenesis of oral submucous fibrosis: A preliminary prospective study.

G K Shakunthala1, Rajeshwari G Annigeri2, Shantala Arunkumar3.   

Abstract

BACKGROUND: In the current scenario pathogenesis of majority of the diseases is deeply linked with the oxidative stress, irrespective of its etiology. Enumerable data suggests that reactive oxygen species play a key role in multistage carcinogenesis. Oral submucous fibrosis (OSMF) is considered as a potentially malignant disorder. Its increased incidence over recent years in the Indian subcontinent is a major health concern to oral physicians. However, the role of oxidative stress has not been widely investigated in OSMF. AIMS: Is to evaluate both antioxidant and oxidant status in OSMF and to compare with controls. SETTINGS AND
DESIGN: Twenty patients and 20 controls of the same age group were enrolled in the study. SUBJECTS AND METHODS: Five milliliters of blood were collected from each individual and serum was separated. Malondialdehyde (MDA) estimation using thiobarbituric acid (TBA) method, and antioxidant activity (AOA) using principle of TBA reactive substances was done using this serum, with a calorimetric method. STATISTICAL ANALYSIS USED: Student's t-test and ANOVA test.
RESULTS: The mean serum AOA status was seen to significantly decrease in OSMF patients, as compared to controls (P = 0.013). The increase in mean serum MDA level was highly significant in OSMF patients, as compared to controls (P < 0.001).
CONCLUSION: The disparity between AOA and MDA levels in the patients clearly demonstrates the role of oxidative stress in the disease process. The results also suggest the use of antioxidants in the management of OSMF.

Entities:  

Keywords:  Antioxidant activity; malondialdehyde; oral submucous fibrosis; oxidative stress

Year:  2015        PMID: 26604570      PMCID: PMC4632219          DOI: 10.4103/0976-237X.166823

Source DB:  PubMed          Journal:  Contemp Clin Dent        ISSN: 0976-2361


Introduction

Oral submucous fibrosis (OSMF) is a chronic, irreversible disease with significant functional morbidity and increased potential for malignant transformation. The pathogenesis is till now unsettled and is believed to be multifactorial in origin. Currently, the focus of pathogenesis is on the oxidative stress. Reactive oxygen species (ROS), concerned with multistage carcinogenesis, are generated in substantial amounts during chewing of areca nut.[1] The role of oxidative stress has not been widely investigated in OSMF. With this view, the present study was undertaken to estimate the total antioxidant activity (AOA) status and malondialdehyde (MDA) levels in OSMF patients and controls.

Subjects and Methods

A total of 20 OSMF patients and 20 age-matched healthy controls, attending the outpatient Department of Oral Medicine and Radiology, in a Dental School in South India were enrolled in the study. Ethical clearance was obtained from the College Ethical Committee and written informed consent was obtained from the patients. Patients were subjected to detailed history regarding systemic condition, psychological status, habit duration, frequency, and quid keeping time. A complete clinical examination was also recorded, on a standard pro forma, followed by a biopsy. Patients with any systemic diseases and significant pathologies in the oral cavity were excluded from the study. Clinical staging was done based on mouth opening into Stage I: >40 mm, Stage II: 31–40 mm, Stage III: 21–30 mm, Stage IV: 11–20 mm, Stage V: 0–10 mm and histopathological grading was done according to Utsunomiya et al.[2] Five milliliters of blood were collected from each individual, using aseptic measures, and samples were centrifuged at 3000 RPM for 10 min and serum was separated immediately after blood centrifugation. Serum was used immediately for analysis or was stored in small aliquots with caps at − 20°C for a maximum of 1 month until assayed. MDA estimation was done using thiobarbituric acid (TBA) method, and AOA was estimated using the principle of TBA reactive substances, by the calorimetric method.[34] Data analysis was done using Statistical Package for Social Science (SPSS, version 10.5) software manufactured by IBM corporation. Student's t-test and ANOVA test were used for statistical analysis. Results were expressed as mean ± standard deviation (SD), and P < 0.05 was considered as statistically significant.

Results

The mean age of study population was 25.7 years with age range of 18–38 years. All the patients in the study group were males. According to clinical staging based on mouth opening, 4 (20%) were in Stage I, and 6 (30%), 8 (40%), and 2 (10%) were in Stage II, Stage III, and Stage IV, respectively. Based on histopathological grading, 5 (25%) were in the early stage, 7 (35%) and 8 (40%) belonged to the intermediate stage, and advanced stage, respectively. In the present study mean serum AOA status of OSMF patient was 1.51 ± 0.52 mmol/L (mean ± SD) and in control group it was 1.92 ± 0.47 mmol/L (mean ± SD) [Table 1]. The mean serum AOA status was significantly decreased in OSMF patients as compared to controls (P = 0.013). There was no significant difference between mean AOA status among patients with different clinical staging and histopathological grading.
Table 1

Comparison of serum AOA status (mmol/L) between controls and cases

Comparison of serum AOA status (mmol/L) between controls and cases The mean serum MDA levels among OSMF patients were 3.60 ± 0.91 nmol/ml (mean ± SD) and in control group, it was 1.78 ± 0.43 nmol/ml (mean ± SD) [Table 2]. The increase in mean serum MDA level was highly significant in OSMF patients, as compared to controls (P < 0.001). However, no significant difference was noted in serum MDA levels among different clinical staging and histopathological grading.
Table 2

Comparison of serum MDA levels (nmol/ml) between controls and cases

Comparison of serum MDA levels (nmol/ml) between controls and cases

Discussion

In the present study, mean serum AOA status in OSMF patients were significantly lower than that of the control group, with a mean reduction of 0.41 mmol/L in OSMF patients. Serum AOA status was compared with different clinical and histopathological grading and there was no significant difference noted. Reduced antioxidant status noticed in our patients may be attributed to excessive utilization of antioxidants from the body, in order to scavenge the free radicals, generated during the pathogenesis of the disease. Reduced intake of food due to decreased mouth opening and burning sensation could well be another contributing factor. To the best of our knowledge, there is no published data where total AOA status has been estimated in OSMF patients. However, observations from the present study were in accordance with other studies where individual antioxidant levels have been estimated. Gupta et al. observed that serum β carotene and Vitamin E levels were considerably reduced in OSMF as compared to controls.[5] Metkari et al. noticed that superoxide dismutase and Vitamin A levels were reduced in OSMF as compared to controls.[6] Mean serum MDA levels in OSMF patients were considerably increased as compared to controls, with a mean difference of 1.82 nmol/ml and the difference was statistically highly significant (P < 0.001). Increased MDA noticed in our study can be credited to the oxidative stress taking place in OSMF patients as demonstrated by increased heat shock protein 70, head-out immersion and nitric oxide synthase.[789] The detection of products of lipid peroxidation in biological materials has provided the basis for several popular assays for ROS and determines the involvement of oxidative stress in the pathogenesis of particular disease.[10] Results from the current study are in accordance with the various other studies like Gupta et al. and Metkari et al. who noticed increase in MDA levels in OSMF patients.[56]

Conclusion

From the present study, it is evident that by estimating lipid peroxidation end product and total AOA status in serum of OSMF patients, we can estimate the amount of oxidative stress tissues are undergoing during the process of pathogenesis. Hence, the administration of antioxidant supplements may be helpful in combating the disease. Further trials in this regard should be carried out to investigate the probable mechanisms by which ROS contributes for pathogenesis of OSMF. A long-term follow-up studies have to be carried out in order to draw a link between oxidative stress and malignant transformation in OSMF patients.
  9 in total

1.  Method for the measurement of antioxidant activity in human fluids.

Authors:  D Koracevic; G Koracevic; V Djordjevic; S Andrejevic; V Cosic
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.

Authors:  Hiroko Utsunomiya; Wanninayake M Tilakaratne; Kazufumi Oshiro; Satoshi Maruyama; Makoto Suzuki; Hiroko Ida-Yonemochi; Jun Cheng; Takashi Saku
Journal:  J Oral Pathol Med       Date:  2005-09       Impact factor: 4.253

3.  Effects of vitamin E, ascorbic acid and mannitol on alloxan-induced lipid peroxidation in rats.

Authors:  C J Dillard; K J Kunert; A L Tappel
Journal:  Arch Biochem Biophys       Date:  1982-06       Impact factor: 4.013

4.  Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.

Authors:  M Thubashini; N Malathi; L Kannan
Journal:  Indian J Dent Res       Date:  2011 Mar-Apr

5.  Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis.

Authors:  C-H Tsai; S-F Yang; S-S Lee; Y-C Chang
Journal:  Oral Dis       Date:  2009-05       Impact factor: 3.511

6.  Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis.

Authors:  Soma Gupta; M V R Reddy; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2004-01

7.  Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.

Authors:  R Rajendran; Shirley Varkey
Journal:  Indian J Dent Res       Date:  2007 Jul-Sep

8.  Free radicals, antioxidants in disease and health.

Authors:  Lien Ai Pham-Huy; Hua He; Chuong Pham-Huy
Journal:  Int J Biomed Sci       Date:  2008-06

9.  Role of lime in the generation of reactive oxygen species from betel-quid ingredients.

Authors:  U J Nair; G Obe; M Friesen; M T Goldberg; H Bartsch
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  9 in total
  5 in total

Review 1.  Depleting levels of endogenous anti-oxidant superoxide dismutase in oral sub-mucous fibrosis: A systematic review and meta-analysis.

Authors:  Khadijah Mohideen; C Krithika; Nadeem Jeddy; Shaheen Shamsuddin; Sulphi Abdul Basheer; Shan Sainudeen; Asma Ahmed Alomar; Samirah Ahmed Sahly; Shazia Mushtaq; A Thirumal Raj; Alessio Zanza; Luca Testarelli; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2022-04-14

Review 2.  A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis.

Authors:  Luciano Saso; Ahmad Reza; Emily Ng; Kimtrang Nguyen; Sheng Lin; Pangzhen Zhang; Paolo Junior Fantozzi; Guliz Armagan; Umberto Romeo; Nicola Cirillo
Journal:  Antioxidants (Basel)       Date:  2022-04-28

Review 3.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

4.  Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.

Authors:  Arulmozhi Nandakumar; Priyadharsini Nataraj; Amritha James; Rajkumar Krishnan; Mahesh K M
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01

5.  A Meta-Analysis in Assessing Oxidative Stress Using Malondialdehyde in Oral Submucous Fibrosis.

Authors:  Khadijah Mohideen; Chandrasekaran Krithika; Nadeem Jeddy; Sameena Parveen; Thangavelu Radhika; S Leena Sankari
Journal:  Eur J Dent       Date:  2021-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.